Eisai's Coats on 2013 Sales of Arena's Obesity Drug

June 4 (Bloomberg) -- Lonnel Coats, head of Eisai Co.'s U.S. unit, and Jack Lief, chief executive officer of Arena Pharmaceuticals Inc., talk about Arena's Belviq weight-loss pill. Eisai will market the drug in the U.S. The speak with Olivia Sterns at the Jefferies 2013 Global Healthcare Conference in Manhattan on Bloomberg Television's "Street Smart." Bloomberg's Adam Johnson also speaks. (Source: Bloomberg)

Abengoa's Bondholders Jumping Ship
27:33 - Creditors of the troubled Spanish renewable energy company, Abengoa, are facing tough choices this morning. They're being told to dump their holdings in the firm or take their chances in an eventual settlement. Abengoa has been teetering on the edge of becoming Spain's biggest corporate bankruptcy. Bloomberg's Rodrigo Orihuela reports on "Countdown." (Source: Bloomberg)
  • Geopolitics Don't Influence Markets for Long: Wyllie
  • Hollande to Meet Putin in Bid to Expand Alliance
  • Rio Tinto's Jacques Sees Copper Prices Recovering